MedTrace Logo

Diluting With Cerebrospinal Fluid Versus Traditional Intrathecal Administration: Antishivering Effects

NCT02189655 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2019-11-20

No results posted yet for this study

Summary

This prospective randomized double-blinded study was conducted to compare the antishivering effects of two different types of intrathecal administration.

Conditions

  • Antishivering Effects

Interventions

PROCEDURE

bupivacaine 0.5% 2.5 mL diluting with cerebrospinal fluid

Hyperbaric bupivacaine 0.5% 2.5 mL diluting with cerebrospinal fluid was administered intrathecally in 30 seconds

Sponsors & Collaborators

  • China Medical University, China

    lead OTHER

Principal Investigators

  • Hong Ma, M.D.,Ph.D · The First Hospital of CMU

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02189655 on ClinicalTrials.gov